You are here:
Consumer Guide to Insulin
Intermediate and long-acting insulins
Onset approx 30 minutes to one hour after injection. Duration of action around 18 - 24 hours. These are described as basal insulins and are designed to work “quietly” all day.
| Marketing Name | Insulin Type | Presentation | Appearance | Manufacturer | Subsidised? | Pharmaceutical Name |
|---|---|---|---|---|---|---|
Humulin NPH (formerly Humulin N)![]() |
Human | 3ml cartridge, 10ml vial | Cloudy suspension | Eli Lilly | Yes | Insulin Isophane |
| Protaphane Penfill | Human | 3ml cartridge | Cloudy suspension | Novo Nordisk | Yes | Insulin Isophane |
| Protaphane | Human | 10ml vial | Cloudy suspension | Novo Nordisk | Yes | Insulin Isophane |
Lantus![]() |
3ml cartridge, 10ml vial | Clear | Sanofi Aventis | Fully funded from 1 July 2006. Subject to Special Authority1 | Insulin Glargine | |
| Lantus Solo Star | Human | Disposable, Pen 3ml |
Clear | Sanofi Aventis | Fully funded from 1 July 2006. | Insulin Glargine |
Levemir![]() |
Disposable Pen | Clear | Novo Nordisk | Not subsidised. Prices will differ. Minimum cost is $169.50 for a box of five 3ml disposable pens | Insulin Detemir | |
View information about other insulins:
Or return to Introduction & Contents page »


